pre-IPO PHARMA

COMPANY OVERVIEW

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation.


LOCATION

  • Cambridge, MA, USA
  • New York, NY, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://www.egenesisbio.com


    CAREER WEBSITE

    https://www.egenesisbio.com/careers/


    SOCIAL MEDIA


    INVESTORS

    alta-partners arch-venture-partners biomatics-capital fresenius-medical-care-ventures khosla-ventures leaps-by-bayer wellington-partners


    PRESS RELEASES


    Jun 9, 2021

    eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors


    Jun 9, 2021

    eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors


    Apr 1, 2021

    eGenesis Expands Research Collaboration with Leading Academic Medical Center


    Mar 4, 2021

    eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer


    Mar 4, 2021

    eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer


    For More Press Releases


    Google Analytics Alternative